The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III study of neoadjuvant chemotherapy with docetaxel(D), oxaliplatin(O), and S-1(S) (DOS) followed by surgery and adjuvant S-1 vs. surgery and adjuvant S-1 for resectable advanced gastric cancer (PRODIGY).
 
Yoon-Koo Kang
Consulting or Advisory Role - Lilly/ImClone; Novartis; Ono Pharmaceutical; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Bayer; Novartis; Roche/Genentech
 
Jeong Hwan Yook
No Relationships to Disclose
 
Min-Hee Ryu
No Relationships to Disclose
 
Jong Seok Lee
No Relationships to Disclose
 
Youngkyu Park
No Relationships to Disclose
 
Ik-Joo Chung
No Relationships to Disclose
 
Minkyu Jung
No Relationships to Disclose
 
Young Woo Kim
No Relationships to Disclose
 
Mi-Jung Kim
No Relationships to Disclose
 
Sang Cheul Oh
No Relationships to Disclose
 
Samyong Kim
No Relationships to Disclose
 
Jong Gwang Kim
No Relationships to Disclose
 
Hong-Suk Song
No Relationships to Disclose
 
Seung Wan Ryu
No Relationships to Disclose
 
Sang Young Roh
No Relationships to Disclose
 
Myeong-Cherl Kook
No Relationships to Disclose
 
Kyoo Jung Shim
Employment - Jeil Pharmaceutical Co
Leadership - Jeil Pharmaceutical Co
 
Jeehyun Lee
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Gyunji Kim
Employment - Sanofi
 
Sung Hoon Noh
No Relationships to Disclose